Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Dec 20;9:1323–1339. doi: 10.2147/JHC.S392056

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Huang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

ARFIP2 deficiency inhibits the proliferation, invasion and migration of HCC cells. (A) qPCR and WB analyses were used to detect the expression of ARFIP2 in four HCC cell lines. (B) qPCR and WB analysis of ARFIP2 expression in HepG2 cells transfected with siARFIP2 #1, #2, or #3 and siCtrl. (C) A colony formation assay was performed to assess the proliferation ability of HepG2 cells following transfection with control siRNA or ARFIP2 siRNA. (D) Transwell assays were used to detect the potential effect of ARFIP2 on invasion. (E) Transwell assays were used to detect the potential effect of ARFIP2 on migration. **P < 0.01.